Event chart NOVOCURE LIMITED |
|
|
Upcoming events on NOVOCURE LIMITED |
|
07/28/22 | | Interim 2022 Earnings Release |
07/28/22 | 08:00am | | Interim 2022 Earnings Call |
10/27/22 | | Q3 2022 Earnings Release (Projected) |
02/23/23 | | FY 2022 Earnings Release (Projected) |
04/27/23 | | Q1 2023 Earnings Release (Projected) |
07/27/23 | | Interim 2023 Earnings Release (Projected) |
|
Past events on NOVOCURE LIMITED |
|
06/08/22 | 09:00am | | Annual General Meeting |
04/28/22 | 08:00am | | Q1 2022 Earnings Call |
04/28/22 | 07:00am | | Q1 2022 Earnings Release |
04/08/22 | | American Association of Cancer Research Meeting - Abstract No CT234 |
04/08/22 | | American Association of Cancer Research Meeting - Abstract No 4138 |
04/08/22 | | American Association of Cancer Research Meeting - Abstract No 3447 |
04/08/22 | | American Association of Cancer Research Meeting - Abstract No 1801 |
04/08/22 | | American Association of Cancer Research Meeting - Abstract No 2659 |
04/08/22 | | American Association of Cancer Research Meeting - Abstract No 1866 |
04/08/22 | | American Association of Cancer Research Meeting - Abstract No 299 |
|
Past dividends on NOVOCURE LIMITED |
|
- No events available -
|
|
Fiscal Period : December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
Sales M $ |
Released Forecast Spread | 177 177 0,00% | 248 247 0,51% | 351 351 0,05% | 494 494 0,14% | 535 539 -0,81% | 552 |
Operating income (EBITDA) M $ |
Released Forecast Spread | -31,7 -10,5 -200% |
| 7,55 9,20 -18% | 39,6 40,3 -1,9% | -34,1 -20,6 -66% | -44,4 |
Operating profit (EBIT) M $ |
Released Forecast Spread | -39,3 -42,3 7,0% | -33,7 -31,7 -6,3% | -0,91 6,79 -113% | 30,4 34,9 -13% | -44,3 -28,8 -54% | -47,9 |
Pre-Tax Profit (EBT) M $ |
Released Forecast Spread | -48,5 -53,3 9,0% | -45,9 -44,6 -3,0% | -8,82 -2,12 -316% | 18,1 25,8 -30% | -52,1 -36,7 -42% | -58,3 |
Net income M $ |
Released Forecast Spread | -61,7 -59,9 -2,9% | -63,6 -61,3 -3,7% | -7,23 -10,5 31% | 19,8 28,8 -31% | -58,4 -41,1 -42% | -62,6 |
EPS $ |
Released Forecast Spread | -0,70 -0,68 -3,1% | -0,69 -0,65 -5,7% | -0,07 -0,10 32% | 0,20 0,26 -24% | -0,56 -0,41 -37% | -0,58 | Announcement Date | 02/22/2018 | 02/28/2019 | 02/27/2020 | 02/25/2021 | 02/24/2022 | - |
|
|
Fiscal Period : December | 2020 Q1 | 2020 Q2 | 2020 Q3 | 2020 Q4 | 2021 Q1 | 2021 Q2 | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 |
Sales M $ |
Released Forecast Spread | 102 102 -0,27% | 116 106 9,4% | 133 120 11% | 144 143 0,33% | 135 139 -3,3% | 134 142 -5,9% | 134 141 -5,4% | 133 134 -0,95% | 138 134 2,4% | 135 | 138 | 141 | 144 | 145 |
Operating income (EBITDA) M $ |
Released Forecast Spread | -1,49 7,08 -121% | 9,27 9,26 0,15% | 17,2 11,0 56% | 14,6 18,6 -21% | 2,28 9,27 -75% | -9,82 4,92 -300% | -5,82 -5,96 2,4% | -20,7 -4,23 -390% | 1,80 -20,3 109% | -11,6 | -14,6 | -16,9 | -9,32 | -10,9 |
Operating profit (EBIT) M $ |
Released Forecast Spread | -3,38 4,48 -176% | 6,67 0,58 1 041% | 15,0 9,62 56% | 12,1 16,6 -27% | -0,09 2,72 -103% | -12,3 2,79 -541% | -8,55 -6,34 -35% | -23,4 -7,85 -198% | -0,81 -18,4 96% | -13,4 | -14,7 | -19,0 | -12,1 | -13,8 |
Pre-Tax Profit (EBT) M $ |
Released Forecast Spread | -5,81 2,30 -353% | 4,05 -1,99 304% | 11,0 7,16 54% | 8,83 16,6 -47% | -2,73 3,43 -180% | -13,2 2,10 -729% | -10,5 -7,76 -36% | -25,6 -10,2 -151% | -2,52 -22,1 89% | -15,0 | -17,3 | -23,4 | -13,8 | -15,5 |
Net income M $ |
Released Forecast Spread | 3,95 3,07 29% | 1,66 0,12 1 329% | 9,28 4,59 102% | 4,92 13,9 -65% | -4,13 2,26 -283% | -14,6 1,23 -1 286% | -13,1 -7,57 -73% | -26,5 -11,1 -138% | -4,65 -19,9 77% | -15,4 | -16,9 | -21,5 | -12,5 | -13,9 |
EPS $ |
Released Forecast Spread | 0,04 0,02 87% | 0,02 0,00 651% | 0,09 0,04 129% | 0,05 0,13 -61% | -0,04 0,02 -278% | -0,14 0,01 -1 698% | -0,13 -0,07 -76% | -0,25 -0,11 -134% | -0,04 -0,19 79% | -0,14 | -0,16 | -0,20 | -0,12 | -0,13 | Announcement Date | 04/30/2020 | 07/30/2020 | 10/29/2020 | 02/25/2021 | 04/29/2021 | 07/29/2021 | 10/28/2021 | 02/24/2022 | 04/28/2022 | - | - | - | - | - | |
|
|
Upcoming sector events for NOVOCURE LIMITED |
|
|
|
Past sector events for NOVOCURE LIMITED |
|
|
|
|
|
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise
|